{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:50:33Z","timestamp":1787590233058,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-32407-x","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:37:39Z","timestamp":1766399859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Delivery of lipid nanoparticles containing small interfering RNA targeting transmembrane serine protease 4 in a human gastric cancer model using nude mice"],"prefix":"10.1038","volume":"15","author":[{"given":"Hirofumi","family":"Tazawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"32407_CR1","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1001\/jama.2010.534","volume":"303","author":"GASTRIC (Global Advanced\/Adjuvant Stomach Tumor Research International Collaboration) Group","year":"2010","unstructured":"GASTRIC (Global Advanced\/Adjuvant Stomach Tumor Research International Collaboration) Group et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA 303, 1729\u20131737. https:\/\/doi.org\/10.1001\/jama.2010.534 (2010).","journal-title":"JAMA"},{"key":"32407_CR2","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1001\/jama.2010.534","volume":"357","author":"S Sakamoto","year":"2007","unstructured":"Sakamoto, S. et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl. J. Med. 357, 1810\u20131820. https:\/\/doi.org\/10.1001\/jama.2010.534 (2007).","journal-title":"N Engl. J. Med."},{"key":"32407_CR3","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1200\/JCO.2011.36.5908","volume":"29","author":"M Sasako","year":"2011","unstructured":"Sasako, M. et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J. Clin. Oncol. 29, 4387\u20134393. https:\/\/doi.org\/10.1200\/JCO.2011.36.5908 (2011).","journal-title":"J. Clin. Oncol."},{"key":"32407_CR4","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1200\/JCO.18.01138","volume":"37","author":"K Yoshida","year":"2019","unstructured":"Yoshida, K. et al. Addition of docetaxel to oral fluoropyrimidine improves efficacy in patients with stage III gastric cancer: interim analysis of JACCRO GC-07, a randomized controlled trial. J. Clin. Oncol. 37, 1296\u20131304. https:\/\/doi.org\/10.1200\/JCO.18.01138 (2019).","journal-title":"J. Clin. Oncol."},{"key":"32407_CR5","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s12276-023-00975-5","volume":"55","author":"S Kim","year":"2023","unstructured":"Kim, S. TMPRSS4, a type II transmembrane Serine protease, as a potential therapeutic target in cancer. Exp. Mol. Med. 55, 716\u2013724. https:\/\/doi.org\/10.1038\/s12276-023-00975-5 (2023).","journal-title":"Exp. Mol. Med."},{"key":"32407_CR6","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/febs.13971","volume":"284","author":"LM Tanabe","year":"2017","unstructured":"Tanabe, L. M. & List, K. The role of type II transmembrane Serine protease-mediated signaling in cancer. FEBS 284, 1421\u20131436. https:\/\/doi.org\/10.1111\/febs.13971 (2017).","journal-title":"FEBS"},{"key":"32407_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.canlet.2019.03.013","volume":"453","author":"F Exposito","year":"2019","unstructured":"Exposito, F. et al. Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery. Cancer Lett. 453, 21\u201333. https:\/\/doi.org\/10.1016\/j.canlet.2019.03.013 (2019).","journal-title":"Cancer Lett."},{"key":"32407_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11605-021-05101-2","volume":"26","author":"H Tazawa","year":"2022","unstructured":"Tazawa, H. et al. Utility of TMPRSS4 as a prognostic biomarker and potential therapeutic target in patients with gastric cancer. J. Gastrointest. Surg. 26, 305\u2013313. https:\/\/doi.org\/10.1007\/s11605-021-05101-2 (2022).","journal-title":"J. Gastrointest. Surg."},{"key":"32407_CR9","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1007\/s00595-024-02824-y","volume":"54","author":"S Tazuma","year":"2024","unstructured":"Tazuma, S. et al. Effects of transmembrane Serine protease 4 on the survival in patients with pancreatic ductal adenocarcinoma undergoing surgery followed by adjuvant chemotherapy. Surg. Today. 54, 1208\u20131219. https:\/\/doi.org\/10.1007\/s00595-024-02824-y (2024).","journal-title":"Surg. Today"},{"key":"32407_CR10","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.4240\/wjgs.v16.i8.2555","volume":"16","author":"Y Shibata","year":"2024","unstructured":"Shibata, Y. et al. Transmembrane Serine protease 4 expression in the prognosis of radical resection for biliary tract cancer. World J. Gastrointest. Surg. 16, 2555\u20132564. https:\/\/doi.org\/10.4240\/wjgs.v16.i8.2555 (2024).","journal-title":"World J. Gastrointest. Surg."},{"key":"32407_CR11","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/hep.31076","volume":"72","author":"ZR Dong","year":"2020","unstructured":"Dong, Z. R. et al. TMPRSS4 drives angiogenesis in hepatocellular carcinoma by promoting HB-EGF expression and proteolytic cleavage. Hepatology 72, 923\u2013939. https:\/\/doi.org\/10.1002\/hep.31076 (2020).","journal-title":"Hepatology"},{"key":"32407_CR12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/carcin\/bgq024","volume":"31","author":"S Kim","year":"2010","unstructured":"Kim, S. et al. TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin \u03b1 and its signaling pathways. Carcinogenesis 31, 597\u2013606. https:\/\/doi.org\/10.1093\/carcin\/bgq024 (2010).","journal-title":"Carcinogenesis"},{"key":"32407_CR13","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/bjc.2013.761","volume":"110","author":"L Larzabal","year":"2014","unstructured":"Larzabal, L. et al. Tmprss4 regulates levels of integrin \u03b15 in NSCLC through miR-205 activity to promote metastasis. Br. J. Cancer. 110, 764\u2013774. https:\/\/doi.org\/10.1038\/bjc.2013.761 (2014).","journal-title":"Br. J. Cancer"},{"key":"32407_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2014.01.013","volume":"446","author":"HJ Min","year":"2014","unstructured":"Min, H. J., Lee, M. K., Lee, J. W. & Kim, S. TMPRSS4 induces cancer cell invasion through pro-uPA processing. Biochem. Biophys. Res. Commun. 446, 1\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2014.01.013 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"32407_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/bjc.2014.403","volume":"112","author":"AL de Aberasturi","year":"2015","unstructured":"de Aberasturi, A. L., Calvo, A. & TMPRSS TMPRSS4: an emerging potential therapeutic target in cancer. Br. J. Cancer. 112, 4\u20138. https:\/\/doi.org\/10.1038\/bjc.2014.403 (2015).","journal-title":"Br. J. Cancer"},{"key":"32407_CR16","doi-asserted-by":"publisher","first-page":"8385","DOI":"10.1038\/s41598-025-93422-6","volume":"15","author":"H Tazawa","year":"2025","unstructured":"Tazawa, H. et al. TMPRSS4 as a prognostic biomarker after gastric cancer surgery. Sci. Rep. 15, 8385. https:\/\/doi.org\/10.1038\/s41598-025-93422-6 (2025).","journal-title":"Sci. Rep."},{"key":"32407_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2006.07.007","volume":"126","author":"DM Dykxhoorn","year":"2006","unstructured":"Dykxhoorn, D. M. & Lieberman, J. Knocking down disease with SiRNAs. Cell 126, 21\u201325 (2006).","journal-title":"Cell"},{"key":"32407_CR18","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","volume":"16","author":"JA Kulkarni","year":"2021","unstructured":"Kulkarni, J. A. et al. The current landscape of nucleic acid therapeutics. Nat. Nanotechnol. 16, 630\u2013643. https:\/\/doi.org\/10.1038\/s41565-021-00898-0 (2021).","journal-title":"Nat. Nanotechnol"},{"key":"32407_CR19","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nmat3765","volume":"12","author":"R Kanasty","year":"2013","unstructured":"Kanasty, R., Dorkin, J. R., Vegas, A. & Anderson, D. Delivery materials for SiRNA therapeutics. Nat. Mater. 12, 967\u2013977. https:\/\/doi.org\/10.1038\/nmat3765 (2013).","journal-title":"Nat. Mater."},{"key":"32407_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nbt.1602","volume":"28","author":"SC Semple","year":"2010","unstructured":"Semple, S. C. et al. Rational design of cationic lipids for SiRNA delivery. Nat. Biotechnol. 28, 172\u2013176. https:\/\/doi.org\/10.1038\/nbt.1602 (2010).","journal-title":"Nat. Biotechnol."},{"key":"32407_CR21","doi-asserted-by":"publisher","first-page":"e781","DOI":"10.1002\/ijc.27361","volume":"131","author":"JB Lee","year":"2012","unstructured":"Lee, J. B. et al. Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo. Int. J. Cancer 131, e781-790 (2012).","journal-title":"Int. J. Cancer"},{"key":"32407_CR22","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"K Carol","year":"2010","unstructured":"Carol, K. et al. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 8, e1000412 (2010).","journal-title":"PLoS Biol."},{"key":"32407_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 48, 452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244 (2013).","journal-title":"Bone Marrow Transpl."},{"key":"32407_CR24","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.3390\/pharmaceutics13122053","volume":"13","author":"AG Niculescu","year":"2021","unstructured":"Niculescu, A. G., B\u00eerc\u0103, A. C. & Grumezescu, A. M. New applications of lipid and polymer-based nanoparticles for nucleic acids delivery. Pharmaceutics 13, 2053. https:\/\/doi.org\/10.3390\/pharmaceutics13122053 (2021).","journal-title":"Pharmaceutics"},{"key":"32407_CR25","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nbt.2612","volume":"31","author":"J Gilleron","year":"2013","unstructured":"Gilleron, J. et al. Image-based analysis of lipid nanoparticle-mediated SiRNA delivery, intracellular trafficking and endosomal escape. Nat. Biotechnol. 31, 638\u2013646. https:\/\/doi.org\/10.1038\/nbt.2612 (2013).","journal-title":"Nat. Biotechnol."},{"key":"32407_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"T Coelho","year":"2018","unstructured":"Coelho, T. et al. Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl. J. Med. 379, 11\u201321 (2018).","journal-title":"N Engl. J. Med."},{"key":"32407_CR27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3390\/jpm11060487","volume":"11","author":"W Islam","year":"2021","unstructured":"Islam, W. et al. EPR-effect enhancers strongly potentiate tumor-targeted delivery of nanomedicines to advanced cancers: further extension to enhancement of the therapeutic effect. J. Pers. Med. 11, 487. https:\/\/doi.org\/10.3390\/jpm11060487 (2021).","journal-title":"J. Pers. Med."},{"key":"32407_CR28","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.3390\/pharmaceutics14112520","volume":"14","author":"T Kalita","year":"2022","unstructured":"Kalita, T., Dezfouli, S. A., Pandey, L. M. & Uludag, H. SiRNA functionalized lipid nanoparticles (LNPs) in management of diseases. Pharmaceutics 14, 2520. https:\/\/doi.org\/10.3390\/pharmaceutics14112520 (2022).","journal-title":"Pharmaceutics"},{"key":"32407_CR29","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1039\/d0bm01609h","volume":"9","author":"R Zhang","year":"2021","unstructured":"Zhang, R. et al. Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver. Biomater. Sci. 9, 1449\u20131463. https:\/\/doi.org\/10.1039\/d0bm01609h (2021).","journal-title":"Biomater. Sci."},{"key":"32407_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jconrel.2023.03.016","volume":"357","author":"S Anthiya","year":"2023","unstructured":"Anthiya, S. et al. Targeted SiRNA lipid nanoparticles for the treatment of KRAS-mutant tumors. J. Control Release. 357, 67\u201383. https:\/\/doi.org\/10.1016\/j.jconrel.2023.03.016 (2023).","journal-title":"J. Control Release"},{"key":"32407_CR31","doi-asserted-by":"publisher","first-page":"e0135224","DOI":"10.1371\/journal.pone.0135224","volume":"10","author":"A Keppner","year":"2015","unstructured":"Keppner, A. et al. Epithelial sodium channel-mediated sodium transport is not dependent on the membrane-bound Serine protease CAP2\/TMPRSS4. PLOS One. 10, e0135224. https:\/\/doi.org\/10.1371\/journal.pone.0135224 (2015).","journal-title":"PLOS One"},{"issue":"1","key":"32407_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams, D. et al. Patisiran, an RNAi Therapeutic, for hereditary transthyretin amyloidosis. N Engl. J. Med. 379 (1), 11\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1716153 (2018).","journal-title":"N Engl. J. Med."},{"issue":"10","key":"32407_CR33","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3390\/vaccines12101148","volume":"12","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Recent advances in lipid nanoparticles and their safety concerns for mRNA delivery. Vaccines 12 (10), 1148. https:\/\/doi.org\/10.3390\/vaccines12101148 (2024).","journal-title":"Vaccines"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32407-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32407-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32407-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:07:16Z","timestamp":1777396036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32407-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["32407"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32407-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7287079\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was reviewed and approved by the NHO Central Ethics Committee [Approval Number: 2019-93].","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all of the participants involved in this study. All procedures were accepted by NHO Kure Medical Center and Chugoku Cancer.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"45053"}}